Sanofi To Divest 60% Of Brands In Consumer Healthcare Overhaul
Executive Summary
Sanofi will look to offload around 150 OTC brands as part of a radical overhaul of its Consumer Healthcare operation. The new head of the business Julie Van Ongevalle has unveiled a wide-ranging turnaround plan with the goal of transforming Sanofi into the OTC market leader.
You may also be interested in...
Stada Strikes Deal With Sanofi For Well-Established European Brands
Stada will strengthen its Consumer Healthcare business in key markets like Germany and the UK with the acquisition from Sanofi of an OTC brand portfolio including Opticrom eye drops and Omnivit vitamins.
Stada Strikes Deal With Sanofi For Well-Established European Brands
Stada will strengthen its Consumer Healthcare business in key markets like Germany and the UK with the acquisition from Sanofi of an OTC brand portfolio including Opticrom eye drops and Omnivit vitamins.
Zentiva Grows In Italy With Acquisition Of Sanofi OTC Brands
Zentiva has added the Zerinol and Schoum Solution OTC brands to its Italian portfolio. Meanwhile, the firm has also agreed a “major product acquisition” with Tillomed Spain in the hospital oncology segment.